PET/Computed Tomography Scanning and Precision Medicine: Esophageal Cancer.

Journal Article (Review;Journal Article)

Esophageal cancer commonly has a poor prognosis, which requires an accurate diagnosis and early treatment to improve outcome. Other modalities for staging, such as endoscopic ultrasound imaging and computed tomography (CT) scans, have a role in diagnosis and staging. However, PET with fluorine-18 fluoro-2-deoxy-d-glucose/CT (FDG PET/CT) scanning allows for improved detection of distant metastatic disease and can help to prevent unnecessary interventions that would increase morbidity. FDG PET/CT scanning is valuable in the neoadjuvant chemotherapy assessment and predicting survival outcomes subsequent to surgery. FDG PET/CT scanning detects recurrent disease and metastases in follow-up.

Full Text

Duke Authors

Cited Authors

  • Goel, R; Subramaniam, RM; Wachsmann, JW

Published Date

  • October 2017

Published In

Volume / Issue

  • 12 / 4

Start / End Page

  • 373 - 391

PubMed ID

  • 28867110

Electronic International Standard Serial Number (EISSN)

  • 1879-9809

International Standard Serial Number (ISSN)

  • 1556-8598

Digital Object Identifier (DOI)

  • 10.1016/j.cpet.2017.05.001

Language

  • eng